Curiois to see how many have tried to contact prana regarding their lack of informing the market of the seemingly widespread and significant news of potential for pbt2 to address antibiotic resistance..
I tried for zero response.. Wondering who else has had a try and whether there was a response.
I'm pondering whether asx should be the next entity I try to contact to spur a response from prana on their thought and/or plans on the news ?
PBT Price at posting:
3.7¢ Sentiment: None Disclosure: Held
